Phase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and Other High-Gra...

por Godwin, Colin D., Rodríguez-Arbolí, Eduardo, Othus, Megan, Halpern, Anna B., Appelbaum, Jacob S., Percival, Mary-Elizabeth M., Hendrie, Paul C., Oehler, Vivian G., Keel, Siobán B., Abkowitz, Janis L., Cooper, Jason P., Cassaday, Ryan D., Estey, Elihu H., Walter, Roland B.
Publicado 2022

Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML

por Halpern, Anna B., Rodríguez-Arbolí, Eduardo, Othus, Megan, Garcia, Kelsey-Leigh A., Percival, Mary-Elizabeth M., Cassaday, Ryan D., Oehler, Vivian G., Becker, Pamela S., Appelbaum, Jacob S., Abkowitz, Janis L., Orozco, Johnnie J., Keel, Siobán B., Hendrie, Paul C., Scott, Bart L., Ghiuzeli, M. Cristina, Estey, Elihu H., Walter, Roland B.
Publicado 2023

Hematologic complications with age in Shwachman-Diamond syndrome

por Furutani, Elissa, Liu, Shanshan, Galvin, Ashley, Steltz, Sarah, Malsch, Maggie M., Loveless, Sara K., Mount, Leann, Larson, Jordan H., Queenan, Kelan, Bertuch, Alison A., Fleming, Mark D., Gansner, John M., Geddis, Amy E., Hanna, Rabi, Keel, Sioban B., Lau, Bonnie W., Lipton, Jeffrey M., Lorsbach, Robert, Nakano, Taizo A., Vlachos, Adrianna, Wang, Winfred C., Davies, Stella M., Weller, Edie, Myers, Kasiani C., Shimamura, Akiko
Publicado 2022